ProstACT Update: TARGET Study Ethics Approval

Go back to ProstACT Update: TARGET Study Ethics Approval
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 9.10 -0.41 (4.31%)
Previous Close $9.51    52 Week High $2.18 
Open $9.26    52 Week Low $0.30 
Day High $9.26    P/E N/A 
Day Low $8.98    EPS $-3.32 
Volume 337,218